If shareholders were truly forward looking then they would have seen this shitshow unfolding a mile away.
Current problem: shareholder perception of the board's competence is dire (the result of a poor ousting strategy IMO). The board just demonstrated they blow with the wind, is this best for shareholders?
A surprising lack of cardiotoxicity at Sheba resulted in <1% turnover of SOI.
What fixes this? Some sort of commercial validation / follow the leader type scenario*.
*You buying doesn't seem to cut the mustard anymore.
Ann: Race Strategic Update August 2023, page-560
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
0.035(2.00%) |
Mkt cap ! $302.7M | |||
| Open | High | Low | Value | Volume |
| $1.79 | $1.79 | $1.70 | $916.8K | 527.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 9427 | 1 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.75 |
Change
0.035 ( 0.75 %) |
||||
| Open | High | Low | Volume | ||
| $1.76 | $1.77 | $1.70 | 30396 | ||
| Last updated 15.57pm 07/06/2024 ? | |||||
| RAC (ASX) Chart |